ARCT - Arcturus falls after detailed Phase 1 data for cystic fibrosis therapy
2024-06-07 12:46:11 ET
More on Arcturus Therapeutics
- Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2024 Earnings Call Transcript
- Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosis
- Arcturus gains after early-stage data for cystic fibrosis therapy
- Arcturus Therapeutics Q1 Earnings Preview
- Seeking Alpha’s Quant Rating on Arcturus Therapeutics